Skip to content

Hearing Preservation in Cochlear Implantation Surgery

Evaluating Cochlear Insertion Trauma and Hearing Preservation After Cochlear Implantation (CIPRES): a Study Protocol for a Randomized Single-blind Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07146841
Acronym
CIPRES
Enrollment
48
Registered
2025-08-28
Start date
2020-01-29
Completion date
2027-01-01
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensorineural Hearing Loss

Keywords

Sensorineural Hearing Loss, Cochlear Implantation, Residual Hearing Preservation, Electrocochleography

Brief summary

In order to preserve the residual hearing in patients with sensorineural hearing loss (SNHL) receiving a cochlear implant (CI), the insertion trauma to the delicate and microscopic structures of the cochlea needs to be minimized. The surgical procedure starts with the conventional mastoidectomy-posterior tympanotomy (MPT) approach to the middle ear, and is followed by accessing the cochlea, with either a cochleostomy (CO) or via the round window (RW). Both techniques have their benefits and disadvantages. Another aspect is the design of the electrode array. There are fundamentally two different designs: a \*straight\* lateral wall lying electrode array (LW), or a \*pre-curved\* perimodiolar cochlear lying electrode array (PM). Interestingly, until now, the best surgical approach and type of implant is unknown. Our hypothesis is that the combination of a RW approach and a LW lying electrode array minimizes insertion trauma, leading to better hearing outcome for SNHL patients.

Interventions

PROCEDURERound window insertion

Insertion of the electrode array via the round window.

PROCEDURECochleostomy insertion

Insertion of the electrode array via cochleostomy.

DEVICELateral wall array

Lateral wall electrode array from Advanced Bionics.

DEVICEPeriomodiolar electrode array

Perimodiolar MidScala electrode array from Advanced Bionics.

Sponsors

UMC Utrecht
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomized controlled single-blind trial consisting of four groups: I: RW and LW, II: RW and PM, III: CO and LW and IV: CO and PM.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Severe hearing loss, CI candidate * 18 years of age or older * normal function of middle ear (i.e. no acute middle ear infections) * dutch language proficiency * choice for Advanced Bionics implant

Exclusion criteria

* prior otologic surgery in the implanted ear (excluding tympanostomy tube placement) * inner ear malformation present in the ear to be implanted (i.e. ossification, Mondini malformation) * retrocochlear pathology present in the auditory system to be implanted * neurocognitive disorders * sudden deafness

Design outcomes

Primary

MeasureTime frameDescription
Hearing preservation12 monthsHearing preservation is the main outcome, which will be expressed in percentage. Hearing preservation is calculated by using the preoperative and postoperative puretoneaudiometry (PTA).

Secondary

MeasureTime frameDescription
Scalar position of the electrode array12 monthsScalar position of the electrode array (scala tympani or scala vestibuli assessed by CB-CT)
Electrocochleography12 monthsECochG (among others amplitude in µV) and eCAP (among others amplitude in µV) potentials
Speech perception12 monthsSpeech perception test with/without noise in CVC words correct score (in percentage) with signal to noise ratio of 10 dB.

Countries

Netherlands

Contacts

Primary ContactImogen AML van Beurden, MD
i.a.m.l.vanbeurden-5@umcutrecht.nl+31887555555

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026